WallStreetZenWallStreetZen

NASDAQ: UFPT
Ufp Technologies Inc Stock Forecast, Predictions & Price Target

Analyst price target for UFPT

Based on 1 analyst offering 12 month price targets for Ufp Technologies Inc.
Min Forecast
$255.00+21.63%
Avg Forecast
$255.00+21.63%
Max Forecast
$255.00+21.63%

Should I buy or sell UFPT stock?

Based on 1 analyst offering ratings for Ufp Technologies Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UFPT stock forecasts and price targets.

UFPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-20

1 of 1

Forecast return on equity

Is UFPT forecast to generate an efficient return?

Forecast return on assets

Is UFPT forecast to generate an efficient return on assets?

UFPT revenue forecast

What is UFPT's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$423.8M+5.93%
Avg 2 year Forecast
$454.5M+13.6%
UFPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UFPT revenue growth forecast

How is UFPT forecast to perform vs Medical Devices companies and vs the US market?
Company
5.93%
Industry
9.79%
Market
12.87%
UFPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UFPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UFPT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
UFPT$209.65$255.00+21.63%Buy
ATEC$12.24$21.80+78.10%Strong Buy
INMD$17.02$27.00+58.64%Buy
ESTA$48.54$55.83+15.02%Strong Buy
NVCR$12.23$25.20+106.05%Buy

Ufp Technologies Stock Forecast FAQ

Is Ufp Technologies Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: UFPT) stock is to Buy UFPT stock.

Out of 1 analyst, 0 (0%) are recommending UFPT as a Strong Buy, 1 (100%) are recommending UFPT as a Buy, 0 (0%) are recommending UFPT as a Hold, 0 (0%) are recommending UFPT as a Sell, and 0 (0%) are recommending UFPT as a Strong Sell.

If you're new to stock investing, here's how to buy Ufp Technologies stock.

What is UFPT's revenue growth forecast for 2024-2025?

(NASDAQ: UFPT) Ufp Technologies's forecast annual revenue growth rate of 5.93% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.87%.

Ufp Technologies's revenue in 2024 is $400,072,000.On average, 1 Wall Street analysts forecast UFPT's revenue for 2024 to be $3,238,630,015, with the lowest UFPT revenue forecast at $3,238,630,015, and the highest UFPT revenue forecast at $3,238,630,015.

In 2025, UFPT is forecast to generate $3,473,235,824 in revenue, with the lowest revenue forecast at $3,473,235,824 and the highest revenue forecast at $3,473,235,824.

What is UFPT's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: UFPT) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.67%.

What is UFPT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year UFPT price target, the average UFPT price target is $255.00, with the highest UFPT stock price forecast at $255.00 and the lowest UFPT stock price forecast at $255.00.

The Wall Street analyst predicted that Ufp Technologies's share price could reach $255.00 by Mar 20, 2025. The average Ufp Technologies stock price prediction forecasts a potential upside of 21.63% from the current UFPT share price of $209.65.

What is UFPT's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: UFPT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.